Telemedicine Clinic for Prostate Cancer Patients

Cancer, Treatment-Related Clinical Trial

Official title:

A Pilot Study of a Nurse and Pharmacist Led OTN (Ontario Telemedicine Network) Based Clinic for Management of Prostate Cancer Patients on Oral Therapy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03413865
• Other study ID #: OTN Study
• Status: Recruiting
• Phase: N/A
• Start date: October 28, 2016
• Est. completion date: June 2021

Study information

• Verified date: February 2019
• Source: Grand River Hospital
• Contact: Stacey Hubay, MD, FRCPC
• Phone: 519-749-4370
• Email: stacey.hubay[@]grhosp.on.ca
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: June 2021
• Est. primary completion date: October 2020
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide.

2. Ability to provide consent to study.

3. Willingness to complete study questionnaires and a semi-structured exit interview.

4. Adequate command of the English language to complete study questionnaire and survey.

5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group)

6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group)

Exclusion Criteria:

1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.

2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)

Related Conditions & MeSH terms

• Cancer, Treatment-Related
• Neoplasms, Second Primary
• Prostatic Neoplasms

Intervention

Other:
• Visits conducted via Telemedicine
Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse

Locations

Country	Name	City	State
Canada	Grand River Hospital	Kitchener	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Grand River Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient satisfaction with overall care	The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC	2 Years